Splicing

Overview of Splicing

Definition

Splicing: post-transcriptional RNA processing step. Introns removed, exons joined. Produces mature messenger RNA (mRNA). Essential for eukaryotic gene expression.

Historical Context

Discovered 1977 by Sharp and Roberts. Challenged central dogma via split genes concept. Revealed gene architecture complexity.

General Process

Pre-mRNA synthesized from DNA template. Splice sites recognized. Introns excised. Exons ligated. Mature mRNA exported for translation.

Types of RNA Splicing

Constitutive Splicing

Default splicing mode. Removes all introns. Produces single mRNA isoform from pre-mRNA.

Alternative Splicing

Generates multiple mRNA variants. Variably includes/excludes exons. Increases proteome diversity.

Group I and II Introns

Self-splicing introns in rRNA and tRNA genes. Catalyze own excision without spliceosome.

Trans-Splicing

Exons from separate RNA molecules joined. Occurs in some protozoa and nematodes.

Splicing Mechanism

Splice Site Recognition

Consensus sequences at 5' splice site (GU), branch point (A), and 3' splice site (AG). Recognized by snRNPs and proteins.

Two-Step Transesterification

First step: 2' OH of branch site A attacks 5' splice site phosphate. Lariat intermediate formed. Second step: 3' OH of upstream exon attacks 3' splice site phosphate. Introns excised, exons joined.

Energy Requirement

Splicing is ATP-dependent. ATP hydrolysis facilitates spliceosome assembly and rearrangements. Catalysis itself is energetically neutral.

Catalytic RNA Role

snRNAs in spliceosome act as ribozymes. Catalyze phosphodiester bond cleavage and formation.

The Spliceosome Complex

Composition

Composed of five small nuclear ribonucleoproteins (snRNPs): U1, U2, U4, U5, U6. Over 150 associated proteins.

Assembly Pathway

Stepwise assembly: E complex (U1 binds 5' site), A complex (U2 binds branch point), B complex (tri-snRNP U4/U5/U6 joins), C complex (catalytic activation).

Function

Coordinates splice site recognition, catalysis, and exon ligation. Dynamic structural rearrangements essential.

snRNP Dynamics

U1 and U4 released upon activation. U2, U5, and U6 form catalytic core.

Regulation of Splicing

Splicing Enhancers and Silencers

Exonic/intronic splicing enhancers (ESE/ISE) promote splicing. Silencers (ESS/ISS) repress. Bound by SR proteins or hnRNPs.

RNA Secondary Structures

Stem loops and hairpins affect splice site accessibility. Regulate spliceosome recruitment.

Trans-Acting Factors

SR proteins stimulate, hnRNPs inhibit splice site usage. Balance dictates splicing outcome.

Cellular and Environmental Influences

Signaling pathways modulate splicing factor phosphorylation. Stress, differentiation alter splicing patterns.

Alternative Splicing

Modes

Exon skipping, mutually exclusive exons, alternative 5' or 3' splice sites, intron retention.

Functional Consequences

Protein isoform diversity, tissue-specific expression, developmental regulation.

Regulatory Mechanisms

Controlled by combinatorial splicing factors and cis-elements. Modulated by chromatin state and transcription kinetics.

Examples

Fibronectin, Dscam, Bcl-x genes exhibit complex alternative splicing patterns.

Biological Importance

Gene Expression Complexity

Expands proteome beyond genome size. Enables rapid adaptation.

Developmental Roles

Splicing patterns shift during differentiation and organogenesis.

Cell-Type Specificity

Distinct splicing profiles define neuronal, muscular, immune cells.

Evolutionary Implications

Alternative splicing drives functional innovation and speciation.

Splicing Errors and Diseases

Mutations Affecting Splice Sites

Point mutations disrupt consensus sequences. Result in exon skipping, cryptic splice site activation.

Splicing Factor Dysfunction

Aberrant expression or mutation of splicing regulators causes mis-splicing.

Disease Associations

Cancer, spinal muscular atrophy, beta-thalassemia, retinitis pigmentosa linked to splicing defects.

Therapeutic Targeting

Antisense oligonucleotides and small molecules correct splicing defects.

Experimental Methods

RNA-Seq and Transcriptomics

Detect alternative splicing events genome-wide. Quantify isoform abundance.

RT-PCR and qPCR

Validate specific splice variants. Measure splice junction usage.

Splice Reporter Assays

Use minigenes to analyze splicing regulation in vivo or in vitro.

In Vitro Splicing Systems

Nuclear extracts incubated with synthetic pre-mRNA substrates. Assess splicing efficiency and mechanism.

Splicing in Other Organisms

Bacteria and Archaea

Rare splicing events; self-splicing introns occasionally present.

Lower Eukaryotes

Fewer introns, simpler splicing machinery.

Plants

Complex alternative splicing; stress-responsive regulation.

Metazoans

Highly regulated, extensive alternative splicing.

Therapeutic Applications

Antisense Oligonucleotides (ASOs)

Modulate splicing by blocking splice sites or regulatory elements. Used in spinal muscular atrophy treatment.

Small Molecule Modulators

Alter splicing factor activity or spliceosome dynamics to restore normal splicing.

Gene Therapy Approaches

CRISPR/Cas editing to correct splice site mutations.

Cancer Treatment

Target aberrant splicing in oncogenes and tumor suppressors.

Summary Tables

Key Spliceosome Components

Common Alternative Splicing Types

References

• Sharp, P.A. "Split genes and RNA splicing." Cell, vol. 12, 1977, pp. 1-5.
• Wahl, M.C., Will, C.L., Lührmann, R. "The spliceosome: design principles of a dynamic RNP machine." Cell, vol. 136, 2009, pp. 701-718.
• Black, D.L. "Mechanisms of alternative pre-messenger RNA splicing." Annu Rev Biochem, vol. 72, 2003, pp. 291-336.
• Lee, Y., Rio, D.C. "Mechanisms and regulation of alternative pre-mRNA splicing." Annu Rev Biochem, vol. 84, 2015, pp. 291-323.
• Cooper, T.A., Wan, L., Dreyfuss, G. "RNA and disease." Cell, vol. 136, 2009, pp. 777-793.